Silenseed is participating in the 3rd Annual RAS Targeted Drug Development Summit 2021
May 25, 2021, Modiin, Israel. Amotz Shemi, PhD, CEO of Silenseed will present in September 21-23, 2021 on: KRAS-LODER to Target Pancreatic Cancer: Ongoing Clinical Results from Phase 2 • LODER is a drug delivery product for regional delivery of RNAi-based drug • KRAS-LODER shows encouraging clinical results in pancreatic cancer • Utilization of KRAS-LODER […]